Sanofi’s Framingham facility hit with FDA warning
French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an ...
STAT7h
Pharmalittle: We’re reading about a cancer therapy’s gold rush, FDA warning Sanofi, and more news
A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...
Supplements company Physician's Choice explores sale, sources say
Physician's Choice, a U.S. maker of supplements and probiotics, is exploring a sale that could value the company at over $500 million, according to sources familiar with the matter.
GlobalData on MSN11h
FDA lifts hold on Opella’s trial to support switch of Cialis to OTC drug
The US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer ...
Sanofi Announces Expanded Marketing Authorization For Sarclisa In The EU - Quick Facts
Sanofi (SNYNF, SNY) said the EU has approved Sarclisa in combination with a standard-of-care regimen, bortezomib, lenalidomide, and ...
STAT1d
Sanofi is warned by the FDA over ‘significant’ problems at a key manufacturing plant
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
ENDPOINTS NEWS1d
Sanofi says no sup­ply in­ter­rup­tions af­ter land­ing FDA warn­ing let­ter for US site
A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in ...
FiercePharma1d
Sanofi's consumer health arm Opella secures FDA green light to pursue OTC Cialis study
After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...
BofA survey reveals an optimistic view for 2025 and focus on healthcare and staples
Bank of America’s global fund manager survey revealed that respondents still believe U.S. equities will be the best for ...
pharmaphorum1d
EU approves endometrial, lung cancer drugs from GSK and J&J
Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...
Sanofi says FDA lifted clinical hold on trial for Cialis OTC switch
Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a ...
Food companies want to confuse consumers. The FDA must push back.
Food companies criticize the science supporting front-of-package labeling, delay public consultation periods, push for their ...